Patents by Inventor Sharon Maynard

Sharon Maynard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9925261
    Abstract: Disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1- are also disclosed herein for the treatment of pre-eclampsia or eclampsia.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: March 27, 2018
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: S. Ananth Karumanchi, Sharon Maynard, Vikas P. Sukhatme
  • Publication number: 20160175434
    Abstract: Disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1- are also disclosed herein for the treatment of pre-eclampsia or eclampsia.
    Type: Application
    Filed: January 26, 2015
    Publication date: June 23, 2016
    Inventors: S. Ananth KARUMANCHI, Sharon MAYNARD, Vikas P. SUKHATME
  • Patent number: 7947449
    Abstract: Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia. Also disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1- are also disclosed herein for the treatment of pre-eclampsia or eclampsia.
    Type: Grant
    Filed: August 4, 2008
    Date of Patent: May 24, 2011
    Assignee: Beth Israel Deaconess Medical Center
    Inventors: S. Ananth Karumanchi, Sharon Maynard, Vikas P. Sukhatme
  • Publication number: 20110014197
    Abstract: Disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1—are also disclosed herein for the treatment of pre-eclampsia or eclampsia.
    Type: Application
    Filed: September 28, 2010
    Publication date: January 20, 2011
    Applicant: Beth Israel Deaconess Medical Center
    Inventors: S. Ananth Karumanchi, Sharon Maynard, Vikas P. Sukhatme
  • Patent number: 7846433
    Abstract: Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia. Also disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1—are also disclosed herein for the treatment of pre-eclampsia or eclampsia.
    Type: Grant
    Filed: February 12, 2008
    Date of Patent: December 7, 2010
    Assignee: Beth Israel Deaconess Medical Center
    Inventors: S. Ananth Karumanchi, Sharon Maynard, Vikas P. Sukhatme
  • Publication number: 20090004669
    Abstract: Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia. Also disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1- are also disclosed herein for the treatment of pre-eclampsia or eclampsia.
    Type: Application
    Filed: August 4, 2008
    Publication date: January 1, 2009
    Applicant: Beth Israel Deaconess Medical Center
    Inventors: S. Ananth Karumanchi, Sharon Maynard, Vikas P. Sukhatme
  • Patent number: 7407659
    Abstract: Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia. Also disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1—are also disclosed herein for the treatment of pre-eclampsia or eclampsia.
    Type: Grant
    Filed: July 21, 2003
    Date of Patent: August 5, 2008
    Assignee: Beth Israel Deaconess Medical Center
    Inventors: S. Ananth Karumanchi, Sharon Maynard, Vikas P. Sukhatme
  • Publication number: 20080138342
    Abstract: Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia. Also disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1—are also disclosed herein for the treatment of pre-eclampsia or eclampsia.
    Type: Application
    Filed: February 12, 2008
    Publication date: June 12, 2008
    Inventors: S. Ananth Karumanchi, Sharon Maynard, Vikas P. Sukhatme
  • Patent number: 7335362
    Abstract: Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia. Also disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1- are also disclosed herein for the treatment of pre-eclampsia or eclampsia.
    Type: Grant
    Filed: February 4, 2004
    Date of Patent: February 26, 2008
    Assignee: Beth Israel Deaconess Medical Center
    Inventors: S. Ananth Karumanchi, Sharon Maynard, Vikas P. Sukhatme
  • Publication number: 20050025762
    Abstract: Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia. Also disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1- are also disclosed herein for the treatment of pre-eclampsia or eclampsia.
    Type: Application
    Filed: February 4, 2004
    Publication date: February 3, 2005
    Inventors: S. Ananth Karumanchi, Sharon Maynard, Vikas Sukhatme
  • Publication number: 20040126828
    Abstract: Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia. Also disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1—are also disclosed herein for the treatment of pre-eclampsia or eclampsia.
    Type: Application
    Filed: July 21, 2003
    Publication date: July 1, 2004
    Inventors: S. Ananth Karumanchi, Sharon Maynard, Vikas P. Sukhatme